Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
Viola A, Falco C, D'Elia R, D'Amico MR, Vicari L, Tambaro FP, Correale P, Laudati D, Palmieri S, Ferrara F. Viola A, et al. Among authors: falco c. Eur J Haematol. 2007 Jan;78(1):41-7. doi: 10.1111/j.1600-0609.2006.00777.x. Epub 2006 Oct 17. Eur J Haematol. 2007. PMID: 17042770
Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
Annunziata M, Celentano M, Pocali B, D'Amico MR, Palmieri S, Viola A, Copia C, Falco C, Del Vecchio L, Ferrara F. Annunziata M, et al. Among authors: falco c. Ann Hematol. 2006 Jun;85(6):394-9. doi: 10.1007/s00277-005-0058-0. Epub 2006 Mar 15. Ann Hematol. 2006. PMID: 16538502 Clinical Trial.
Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation.
Iannotta R, Celentano M, Marotta S, Pedata CM, Riccardi C, Migliaccio I, Viola A, Muggianu SM, Falco C, Bovenzi D, Ferrara F, Picardi A. Iannotta R, et al. Among authors: falco c. Leuk Res Rep. 2022 Jul 27;18:100340. doi: 10.1016/j.lrr.2022.100340. eCollection 2022. Leuk Res Rep. 2022. PMID: 35958243 Free PMC article.
Extracorporeal Photopheresis Enhances the Frequency and Function of Highly Suppressive FoxP3+ Treg Subsets in Heart Transplanted Individuals.
Mottola M, Bruzzaniti S, Piemonte E, Lepore MT, Petraio A, Romano R, Castiglione A, Izzo L, Perna F, De Falco C, Brighel F, Formisano L, Gravina MT, Marino M, De Feo M, Matarese G, Galgani M. Mottola M, et al. Among authors: de falco c. Transplantation. 2024 Sep 19. doi: 10.1097/TP.0000000000005201. Online ahead of print. Transplantation. 2024. PMID: 39294864
Quantifying cell cycle regulation by tissue crowding.
Falcó C, Cohen DJ, Carrillo JA, Baker RE. Falcó C, et al. Biophys J. 2024 May 7:S0006-3495(24)00317-5. doi: 10.1016/j.bpj.2024.05.003. Online ahead of print. Biophys J. 2024. PMID: 38715360 Free article.
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.
Abbadessa G, Lepore MT, Bruzzaniti S, Piemonte E, Miele G, Signoriello E, Perna F, De Falco C, Lus G, Matarese G, Bonavita S, Galgani M. Abbadessa G, et al. Among authors: de falco c. Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200250. doi: 10.1212/NXI.0000000000200250. Epub 2024 Apr 25. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38662990 Free PMC article.
169 results